1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [c02270cd-1782-40e7-9bf8-0f97de75fdfe] => Array
        (
            [runtime-id] => c02270cd-1782-40e7-9bf8-0f97de75fdfe
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [7a43c867-3eb1-4dc9-8cd0-118aa541b4fc] => Array
                        (
                            [runtime-id] => 7a43c867-3eb1-4dc9-8cd0-118aa541b4fc
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;ae2bbb8d71f4fc16293027545e23e7df5efeb108
                )

        )

)
1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [563c7d20-7ef8-4f4a-9569-7ad0aaeff80f] => Array
        (
            [runtime-id] => 563c7d20-7ef8-4f4a-9569-7ad0aaeff80f
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [5fe09f72-8784-435a-b494-65f87d420b87] => Array
                        (
                            [runtime-id] => 5fe09f72-8784-435a-b494-65f87d420b87
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;ae2bbb8d71f4fc16293027545e23e7df5efeb108
                )

        )

)
PT  - JOURNAL ARTICLE
AU  - Zhang, L.
AU  - Huang, Q.
AU  - Zhang, Y.
AU  - Liu, J.
AU  - Hong, B.
AU  - Xu, Y.
AU  - Zhao, W.
TI  - Wingspan Stents for the Treatment of Symptomatic Atherosclerotic Stenosis in Small Intracranial Vessels: Safety and Efficacy Evaluation
AID  - 10.3174/ajnr.A2772
DP  - 2012 Feb 01
TA  - American Journal of Neuroradiology
PG  - 343--347
VI  - 33
IP  - 2
4099  - http://www.ajnr.org/content/33/2/343.short
4100  - http://www.ajnr.org/content/33/2/343.full
SO  - Am. J. Neuroradiol.2012 Feb 01; 33
AB  - BACKGROUND AND PURPOSE: Until now, endovascular treatment of symptomatic atherosclerotic stenosis in small intracranial arteries (≤2.5 mm) was limited. We evaluated the safety and efficacy of the treatment by using Wingspan stents in arteries of this caliber. MATERIALS AND METHODS: From March 2007 to July 2010, 53 symptomatic intracranial stenoses with narrowing of at least 50% in 53 patients were treated by using Wingspan stents. Clinical manifestations and imaging features were recorded. RESULTS: The technical success rate was 98.1%. There were no serious complications, with the exception of 1 patient who experienced a small cerebral hemorrhage caused by perforation of microwire. Thirty-nine patients (74%) were available for follow-up imaging with DSA. ISR was documented in 13 of these patients, including 2 patients with symptomatic ISR. The median length of the vascular lesions was 5.39 mm, and patients whose vascular lesions were longer than 5.39 mm had a much higher incidence of ISR than patients whose vascular lesions were shorter than 5.39 mm (53% versus 15%, respectively). The median ratio of the reference artery diameter to the stent diameter was 0.78, and patients whose ratio was smaller than 0.78 had a much higher incidence of ISR than patients whose ratio was larger than 0.78 (53% versus 15%, respectively). CONCLUSIONS: In our series, percutaneous transluminal angioplasty and stent placement of small intracranial arteries by using Wingspan stents was safe. The ISR rate was relatively high; most patients having ISR were asymptomatic. Further follow-up is needed to assess the long-term efficacy of this procedure. ACTactivated clotting timeISRin-stent restenosisLMAlocation, morphology, and accessPTASpercutaneous transluminal angioplasty and stentingWASIDWarfarin Aspirin Symptomatic Intracranial Disease